NEJM Evidence Study Shows Measles Risks for Pregnant Women in U.S.

Federal health scientists published measles pregnancy data in NEJM Evidence after the Centers for Disease Control and Prevention declined a request to issue a national health alert, revealing 112 infected pregnant women and related newborn complications.

  • Pregnant women who contract measles face elevated risks of pneumonia, respiratory failure, and premature delivery, according to new data published in NEJM Evidence.
  • Because the live-attenuated measles, mumps, and rubella (MMR) vaccine is strictly contraindicated during pregnancy, susceptible exposed patients rely on prompt administration of immune globulin containing virus-neutralizing antibodies.
  • Clinicians recommend checking immunity status urgently upon exposure and preparing hospital labor, delivery, and neonatal units for potential congenital cases.

The Pan American Health Organization is scheduled to formally announce the decision publicly on Tuesday.

Eleven developed pneumonia, two experienced respiratory failure, and one was admitted to intensive care.

All but two of the women were unvaccinated or had an unknown vaccination status.

He also pointed to the relatively high proportion requiring intensive care.

Clinical Metric Reported Figure Context / Comparison
Total Cases in Analysis 112 pregnant women Covered 21 months from January 2025 through Sept. 28
Unknown Pregnancy Outcomes 56 women Half of the total analyzed cases

Two more measles deaths were reported on Friday in Wisconsin and Pennsylvania, bringing the U.S. toll this year to at least 10. In 2025, three people died of measles.

Pennsylvania is currently home to the nation’s largest outbreak, reporting more than 1,560 cases.

Nearly all the infections among pregnant women in the national analysis were linked to large outbreaks sweeping through undervaccinated communities since early 2025 in West Texas, Utah, Arizona, South Carolina and other states.

She added that journal articles are for the record, while health alerts are for the patient in front of you today.

The live-attenuated measles, mumps, and rubella (MMR) vaccine is strictly contraindicated for pregnant individuals due to theoretical risks to the fetus. Susceptible pregnant women with documented or suspected exposure to measles must contact an obstetrician immediately to discuss post-exposure prophylaxis with immune globulin within the strict six-day therapeutic window.

Healthcare providers should be consulted urgently if an unvaccinated pregnant individual develops a generalized maculopapular rash, high fever, cough, coryza, or conjunctivitis.

  • NEJM Evidence: Measles in Pregnancy and Newborn Outcomes.
  • Centers for Disease Control and Prevention: Measles in Pregnancy Guidance.
  • Centers for Disease Control and Prevention: Signs and Symptoms of Measles.
  • Centers for Disease Control and Prevention: Health Alert Network Overview.
Photo of author

Priya Deshmukh - Senior Editor, Health

Priya Deshmukh Senior Editor, Health Deshmukh is a practicing physician and renowned medical journalist, honored for her investigative reporting on public health. She is dedicated to delivering accurate, evidence-based coverage on health, wellness, and medical innovations.

US Bank Outages and United Airlines Flight Groundings Spark Tech Chaos